Lobbying client · LD-2 disclosures
Avanir Pharmaceuticals
California
22 filings from 2 registrants · 2014–2022 · latest filed Nov 22, 2022
Reported on its behalf
$1.6M
every LD-2 on file
Its own filed spend
$1.5M
lobbying for itself
Fees to outside firms
$50K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Reported as lobbying expenses
Money reported as spent on lobbying rather than as a fee paid to an outside firm. See the full list.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
16 filings
$1.3M on those filings
Budget/Appropriations
BUD
7 filings
$690K on those filings
Medicare/Medicaid
MMM
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
Who did the lobbying
Every lobbyist named on this client's filings.
- Crystal Lynn Vanuch Avanir PharmaceuticalsCovered position: Head of Government Affairs17 filingsthrough 2017
- Sarah Christine D'Orsie Avanir PharmaceuticalsCovered position: Director of Advocacy8 filingsthrough 2015
- Catherine Dratz Ferguson Avanir Pharmaceuticals7 filingsthrough 2022
- Matthew B Keelen The Keelen Group, LLC4 filingsthrough 2018
- Stephen Borg
The filings
The 20 most recent of 22 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: avanir-pharmaceuticals.